Oral Administration of MB-102 Versus Dual Sugar Testing for Gut Permeability
NCT03962998
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Crohn Disease
Interventions
DRUG:
Lactulose/Rhamnose solution
DRUG:
MB-102
Sponsor
MediBeacon